Honz Pharmaceutical Co., Ltd. engages in the manufacture and distribution of drugs for children. It offers western medicines and Chinese patent drugs, including antipyretic and analgesic drugs, cold drugs, antibiotics drugs, respiratory system drugs, digestant, and arresting convulsion drugs. Its products include nimesulide granules, cefminox sodium for injection, zhike juhong granules, ganmao qingre granules, artificial cow-bezoar and chlorphenamine maleate granules, cefaclor granules, carbocisteine granules, jianerle granules, pediatric vitamins, calcium gluconate granules, ribavirin pellets, and Norfloxacin capsules for adults. The company was founded on January 20, 1994 and is headquartered in Guangzhou, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company